CLINICAL_TRIALS
trial_result
· 2024-05-08
Clinical Trial Update: Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
Summary
A completed trial assessing whether urine interleukin-37 can predict mortality risk in sepsis patients. The study reports results on IL-37 as a prognostic bioma…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Zhongnan Hospital | Conditions: Sepsis | Status: COMPLETED